MCID: NNH003
MIFTS: 12

Non-Hodgkin Lymphoma, Childhood malady

Categories: Rare diseases, Immune diseases

Aliases & Classifications for Non-Hodgkin Lymphoma, Childhood

Aliases & Descriptions for Non-Hodgkin Lymphoma, Childhood:

Name: Non-Hodgkin Lymphoma, Childhood 50

Classifications:



Summaries for Non-Hodgkin Lymphoma, Childhood

MalaCards based summary : Non-Hodgkin Lymphoma, Childhood is related to lymphoma and pneumonia. The drugs Cyclophosphamide and Thiotepa have been mentioned in the context of this disorder.

Related Diseases for Non-Hodgkin Lymphoma, Childhood

Diseases related to Non-Hodgkin Lymphoma, Childhood via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 lymphoma 9.8
2 pneumonia 9.8
3 childhood leukemia 9.8

Symptoms & Phenotypes for Non-Hodgkin Lymphoma, Childhood

Drugs & Therapeutics for Non-Hodgkin Lymphoma, Childhood

Drugs for Non-Hodgkin Lymphoma, Childhood (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 285)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
2
Thiotepa Approved Phase 4,Phase 3,Phase 2,Phase 1 52-24-4 5453
3
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
4 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
5 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
6 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1
7 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
8 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
9
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
10
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
11
Cyclosporine Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
12
Mitoxantrone Approved, Investigational Phase 3,Phase 2,Phase 1 65271-80-9 4212
13
Daunorubicin Approved Phase 3,Phase 2 20830-81-3 30323
14
Vinblastine Approved Phase 3,Phase 1,Phase 2 865-21-4 13342 241903
15
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
16
Etoposide Approved Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
17
Idarubicin Approved Phase 3 58957-92-9 42890
18
Cytarabine Approved, Investigational Phase 3,Phase 2,Phase 1 147-94-4 6253
19
Methotrexate Approved Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
20
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 4053 460612
21
Mycophenolic acid Approved Phase 3,Phase 2,Phase 1 24280-93-1 446541
22
Mycophenolate mofetil Approved, Investigational Phase 3,Phase 2,Phase 1 128794-94-5 5281078
23
Fludarabine Approved Phase 2, Phase 3, Phase 1 21679-14-1, 75607-67-9 30751
24
Busulfan Approved, Investigational Phase 3,Phase 2,Early Phase 1 55-98-1 2478
25
Hydrocortisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-23-7 5754 657311
26
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
27
Prednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-24-8 5755
28
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 22916-47-8 4189
29
Thioguanine Approved Phase 3,Phase 1,Phase 2 154-42-7 2723601
30
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 83-43-2 6741
31
Vindesine Approved Phase 3 59917-39-4, 53643-48-4 40839
32
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
33
Asparaginase Approved Phase 3,Phase 2,Phase 1 9015-68-3
34
Levoleucovorin Approved Phase 3,Phase 2,Phase 1 68538-85-2
35
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 498142 38904
36
deoxycholic acid Approved Phase 3 83-44-3 222528
37
Morphine Approved, Investigational Phase 3 57-27-2 5288826
38
Captopril Approved Phase 3 62571-86-2 44093
39
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
40
Ribavirin Approved Phase 3 36791-04-5 37542
41
Fluconazole Approved Phase 3 86386-73-4 3365
42
rituximab Approved Phase 3,Phase 2,Phase 1 174722-31-7 10201696
43
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
44
Ondansetron Approved Phase 3,Phase 2 99614-02-5 4595
45
Mechlorethamine Approved Phase 3,Phase 1,Phase 2 51-75-2 4033
46
Vancomycin Approved Phase 3 1404-90-6 441141 14969
47
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
48
Tazobactam Approved Phase 3 89786-04-9 123630
49
Piperacillin Approved Phase 3 66258-76-2 43672
50
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449

Interventional clinical trials:

(show top 50) (show all 255)
id Name Status NCT ID Phase
1 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4
2 Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma Unknown status NCT00003728 Phase 3
3 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003650 Phase 3
4 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3
5 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3
6 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3
7 Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation Completed NCT00002456 Phase 3
8 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer Completed NCT00002742 Phase 3
9 Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma Completed NCT01230983 Phase 3
10 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3
11 Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia Completed NCT00005977 Phase 3
12 TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma Completed NCT00002757 Phase 3
13 Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Completed NCT00369564 Phase 3
14 Stem Cell Transplantation for Patients With Hematologic Malignancies Completed NCT00152139 Phase 3
15 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3
16 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3
17 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
18 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
19 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
20 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
21 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3
22 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3
23 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3
24 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3
25 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
26 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
27 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3
28 Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases Completed NCT00438958 Phase 3
29 Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease Completed NCT00003414 Phase 3
30 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3
31 Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Completed NCT00381680 Phase 3
32 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Completed NCT01305200 Phase 3
33 Mature B-Cell Lymphoma And Leukemia Study III Recruiting NCT01046825 Phase 2, Phase 3
34 Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Recruiting NCT02112916 Phase 3
35 Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Recruiting NCT01190930 Phase 3
36 Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia Recruiting NCT02101853 Phase 3
37 Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia Active, not recruiting NCT01595048 Phase 2, Phase 3
38 Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer Active, not recruiting NCT00003816 Phase 2, Phase 3
39 Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma Active, not recruiting NCT00004228 Phase 3
40 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Active, not recruiting NCT00408005 Phase 3
41 Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma Terminated NCT00275106 Phase 3
42 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3
43 Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia Unknown status NCT00008164 Phase 2
44 Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma Unknown status NCT00621036 Phase 2
45 Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders Unknown status NCT00008307 Phase 2
46 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2
47 Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's Lymphoma Completed NCT01761500 Phase 2
48 Statin Therapy in Young Adult Survivors of Childhood Cancer Completed NCT01733953 Phase 2
49 Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma Completed NCT00002738 Phase 2
50 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00006102 Phase 2

Search NIH Clinical Center for Non-Hodgkin Lymphoma, Childhood

Genetic Tests for Non-Hodgkin Lymphoma, Childhood

Anatomical Context for Non-Hodgkin Lymphoma, Childhood

Publications for Non-Hodgkin Lymphoma, Childhood

Variations for Non-Hodgkin Lymphoma, Childhood

Expression for Non-Hodgkin Lymphoma, Childhood

Search GEO for disease gene expression data for Non-Hodgkin Lymphoma, Childhood.

Pathways for Non-Hodgkin Lymphoma, Childhood

GO Terms for Non-Hodgkin Lymphoma, Childhood

Sources for Non-Hodgkin Lymphoma, Childhood

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....